Generic Dossiers & Licensing

Licensing Opportunities

NextPharma develops and registers its own generic dossiers which we then license to sell, market and distribute to partners across the world and as a leading CDMO, can ensure the supply for both product launch and commercial demand.

The following products have been approved in Europe through decentralized procedure:

  • Elevin 20/100: Ethinylestradiol 20µg / Levonorgestrel 100µg
  • Elevin 30/150: Ethinylestradiol 30µg / Levonorgestrel 150µg
  • Diena: Ethinylestradiol 30µg / Dienogest 2000µg
  • Desomono: Desogestrel 75µg